Bicycle Therapeutics (NASDAQ: BCYC) COO reports initial share, RSU and option holdings
Rhea-AI Filing Summary
Bicycle Therapeutics plc Chief Operating Officer Jennifer Scott Perry has filed an initial ownership report showing her equity position in the company. The filing lists direct ownership of 93,872 Ordinary Shares, which includes 84,697 restricted share units that vest in scheduled quarterly installments beginning on April 2, 2026 and April 3, 2026, and in larger tranches from January 2, 2027 onward.
In addition to common shares and RSUs, Perry holds multiple employee stock options over Ordinary Shares with different exercise prices and long-dated expirations. Examples include options over 20,000 underlying Ordinary Shares at an exercise price of $26.4500 expiring on September 1, 2032, and options over 100,000 underlying Ordinary Shares at an exercise price of $7.0800 expiring on January 2, 2036. The vesting footnotes show these options generally vest one-fourth on a specified initial date, with the remaining shares vesting in equal monthly installments over 36 months.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (1)
- The Ordinary Shares may be represented by American Depositary Shares, each of which represents one ordinary share. Includes 84,697 restricted share units ("RSUs"). 447 RSUs vest in four equal quarterly installments commencing on April 3, 2026; 8,000 RSUs vest in eight equal quarterly installments commencing on April 2, 2026; 26,250 RSUs vest in twelve equal quarterly installments commencing on April 2, 2026; and 50,000 RSUs vest one-fourth (1/4) on January 2, 2027 and the remaining RSUs vest in twelve equal quarterly installments thereafter. This option vested with respect to one-fourth (1/4) of the total number of shares underlying the option on August 24, 2023 and the remaining shares vested or vest in 36 equal monthly installments thereafter. This option vested with respect to one-fourth (1/4) of the total number of shares underlying the option on January 3, 2024 and the remaining shares vested or vest in 36 equal monthly installments thereafter. This option vested with respect to one-fourth (1/4) of the total number of shares underlying the option on March 13, 2024 and the remaining shares vested or vest in 36 equal monthly installments thereafter. This option vested with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2025 and the remaining shares vested or vest in 36 equal monthly installments thereafter. This option vested with respect to one-fourth (1/4) of the total number of shares underlying the option on July 16, 2025 and the remaining shares vested or vest in 36 equal monthly installments thereafter. This option vested with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2026 and the remaining shares vested or vest in 36 equal monthly installments thereafter. This option vests with respect to one-fourth (1/4) of the total number of shares underlying the option on January 2, 2027 and the remaining shares vest in 36 equal monthly installments thereafter.